MAPT and Alzheimer disease: The study included 136 memory clinic patients and found similar added values of Aβ and tau PET with an increase in diagnostic certainty and a similar degree of changed diagnoses (28% change) for the 2 PET methods.8 In our study, where fluid AD biomarkers were already known before tau PET imaging was performed, the change in diagnoses was as expected smaller (7.5%).